R&D Integrate or isolate: Incorporating traditional safety-relat... Should traditional safety considerations be treated as distinct from broader ESG frameworks, or fully integrated within them?
R&D Navigating development in a complex molecule world For decades, the pharmaceutical industry has relied on accelerated development and manufacturing timelines to bring new therapies to patients quickly.
News Lilly names Houston as site for $6.5bn API facility Lilly has named Houston as the second of four locations for new manufacturing facilities that are central to a $27bn investment programme in the US.
R&D Supply chain resilience in pharma: Delivering consistency am... In an interconnected economy, industries operating on an international scale are increasingly vulnerable to supply chain disruption.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.